Evidence map›Paper›PMID 40854697›Full record

ArticleJournal of the American Board of Family Medicine : JABFM2025

"Medicine Is Awesome": A Critical Look at the Factors That Shape Thinking About Depression and Its Treatment.

Allen F Shaughnessy, Joshua Passarelli, Sophie Pollack-Milgate, Lisa Cosgrove

Abstract read
In one paragraph

Article in Journal of the American Board of Family Medicine : JABFM, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The 4Cs of Primary Care, Leveraging Artificial Intelligence, and Improving Clinical Practice.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Allen F ShaughnessyFrom the Tufts University Family Medicine Residency at Cambridge Health Alliance, Department of Family Medicine, Tufts University School of Medicine (AFS); Tufts University School of Medicine (JP); Department of Counseling and School Psychology, University of Massachusetts-Boston (SPM); Department of Counseling and School Psychology, University of Massachusetts-Boston (LC). allen.shaughnessy@tufts.edu.
Joshua PassarelliFrom the Tufts University Family Medicine Residency at Cambridge Health Alliance, Department of Family Medicine, Tufts University School of Medicine (AFS); Tufts University School of Medicine (JP); Department of Counseling and School Psychology, University of Massachusetts-Boston (SPM); Department of Counseling and School Psychology, University of Massachusetts-Boston (LC).
Sophie Pollack-MilgateFrom the Tufts University Family Medicine Residency at Cambridge Health Alliance, Department of Family Medicine, Tufts University School of Medicine (AFS); Tufts University School of Medicine (JP); Department of Counseling and School Psychology, University of Massachusetts-Boston (SPM); Department of Counseling and School Psychology, University of Massachusetts-Boston (LC).
Lisa CosgroveFrom the Tufts University Family Medicine Residency at Cambridge Health Alliance, Department of Family Medicine, Tufts University School of Medicine (AFS); Tufts University School of Medicine (JP); Department of Counseling and School Psychology, University of Massachusetts-Boston (SPM); Department of Counseling and School Psychology, University of Massachusetts-Boston (LC).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No longer are prolonged sadness and despondency, with their effects on day-to-day functioning, conceived of as a response to someone's internal world or external environment. Instead, the syndrome has been elevated to a medical disorder-depression-explained as a chemical imbalance in the nervous system that requires medication to rebalance these chemicals. How did we arrive at this modern state of affairs? While the answer to this question is complex and has been hotly debated, one thing is certain: This relatively new explanation of depression as a neurochemical imbalance leads to the current privileging of pharmacotherapy over other approaches to treatment. However, the pharmacologic effect of these treatments is still speculative. Numerous studies have failed to show a benefit to active treatment greater than that seen with placebo, and most patients will not achieve remission of symptoms despite treatment. This overreliance on medication may reflect a "medicine is awesome" stance that biases clinicians toward medical interventions. A more expansive understanding of depressed mood, one that can and should be discussed with patients, is to understand it as a reaction to one's psychosocial, political, economic, and physical environment. This more expansive understanding includes the neurobiological basis of mood, but it also allows for discussions of non-pharmaceutical treatments, ones that can be aligned with each patient's agenda. Medications may be an eventual option after a thorough explanation of limited benefit and possible harms. However, this reframing of depression facilitates a valuable, satisfying means of developing trust and helping people with depressed mood.

Indexed as

Antidepressive AgentsDepressionHumansAntidepressive AgentsAntidepressive AgentsBiomedical ResearchConflict of InterestDepressionEvidence-Based PracticeMedical PhilosophyMental HealthMethodsPharmacologyPsychopharmacologySocial Determinants of HealthSocial StigmaSociology

Identifiers

PMID40854697
PMCPMC12616796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.